November 22, 2026

20053 PYP Pharmacognosy Practical D Pharm

Pharmacognosy Practical, Lab Manual, Journal, PDF

Pharmacognosy Practical D Pharm

1. Morphological Identification of the following drugs:

Ispaghula, Senna, Coriander, Fennel, Cardamom, Ginger, Nutmeg, Black Pepper, Cinnamon, Clove,    Ephedra, Rauwolfia, Gokhru, Punarnava, Cinchona, Agar.

2. Gross anatomical studies (Transverse Section) of the following drugs:

Ajwain, Datura, Cinnamon, Cinchona, Coriander, Ashwagandha, Liquorice, Clove, Curcuma, Nux vomica, Vasaka

3. Physical and chemical tests for evaluation of any FIVE of the following drugs:


Assignments

The students shall be asked to submit the written assignments on the following topics (One assignment per student per sessional period. i.e., a minimum of THREE assignments per student)

1. Market preparations of various dosage forms of Ayurvedic, Unani, Siddha, Homeopathic (Classical and Proprietary), indications, and their labelling requirements

2. Market preparations of various herbal formulations and herbal cosmetics, indications, and their labelling requirements

3. Herb-Drug interactions documented in the literature and their clinical significance


Field Visit

The students shall be taken in groups to a medicinal garden to witness and understand the nature of various medicinal plants discussed in theory and practical courses. Additionally, they shall be taken in groups to the pharmacies of traditional systems of medicines to understand the availability of various dosage forms and their labelling requirements. Individual reports from each student on their learning experience from the field visit shall be submitted.


F Y D Pharm & S Y D Pharm Notes, Books, Syllabus, PDF, Videos

First Year D PharmSecond Year D Pharm
20111 PHT Pharmaceutics Theory20221 PGT Pharmacology Theory
20051 PHP Pharmaceutics Practical20056 PGP Pharmacology Practical
20112 PCT Pharmaceutical Chemistry Theory20222 CMT Community Pharmacy & Management Theory
20052 PCP Pharmaceutical Chemistry Practical20057 CMP Community Pharmacy & Management Practical
20113 PYT Pharmacognosy Theory20223 BCT Biochemistry & Clinical Pathology Theory
20053 PYP Pharmacognosy Practical20058 BCP Biochemistry & Clinical Pathology Practical
20114 HPT Human Anatomy Physiology Theory20224 PTT Pharmacotherapeutics Theory
20054 HPP Human Anatomy Physiology Practical20059 PTP Pharmacotherapeutics Practical
20115 SPT Social Pharmacy Theory20225 HCT Hospital & Clinical Pharmacy Theory
20055 SPP Social Pharmacy Practical20060 HCP Hospital & Clinical Pharmacy Practical
20226 PLT Pharmacy Law & Ethics

Suggested readings


Recommended readings:

  • Building Trust in AI-Enabled Medical Devices: A Comprehensive Approach to FDA Guidelines

    Artificial Intelligence (AI) has emerged as a transformative force in healthcare, enabling groundbreaking advancements in diagnostics, treatment, and patient care. However, with innovation comes responsibility, particularly when it comes to ensuring safety, transparency, and fairness in AI-enabled medical devices. The U.S. Food and Drug Administration (FDA) has provided draft guidelines to establish a framework for…

  • All India Pharmaceutical Association Consortium Launches Programme to Empower MSMEs in Pharma Sector

    All India Pharmaceutical Association Consortium Launches Programme to Empower MSMEs in Pharma Sector The All India Pharmaceutical Association Consortium (AIPAC) is set to launch its maiden programme aimed at empowering professionals from Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical industry. The event, themed “Symposium on Dissolution Science & Technology for QA, QC, R&D…

  • Bio-Techne’s Asuragen Launches High-Sensitivity ESR1 Mutation Monitoring Assay for HR+ Metastatic Breast Cancer Research

    Bio-Techne’s Asuragen Launches High-Sensitivity ESR1 Mutation Monitoring Assay for HR+ Metastatic Breast Cancer Research Bio-Techne Corporation, through its Asuragen brand, has launched a groundbreaking ESR1 mutation monitoring assay aimed at advancing research in hormone receptor-positive (HR+) metastatic breast cancer. This research-use-only assay, featuring a QuantideX qPCR ESR1 exoMutation Kit and an ExoLution Plus cfDNA +…